BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB
61 results:

  • 1. Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
    Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
    Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. High-grade medullary thyroid carcinoma with papillary-like nuclear features: A report of five cases.
    Yamao N; Hirokawa M; Suzuki A; Higuchi M; Ishisaka T; Miyauchi A; Akamizu T
    Diagn Cytopathol; 2024 Jan; 52(1):58-64. PubMed ID: 37846174
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health.
    Durrani IA; Bhatti A; John P
    PLoS One; 2023; 18(8):e0289839. PubMed ID: 37556419
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinoma.
    Hirokawa M; Matsuse M; Mitsutake N; Suzuki A; Higuchi M; Hayashi T; Kamma H; Miyauchi A; Akamizu T
    Diagn Pathol; 2023 Jun; 18(1):74. PubMed ID: 37340328
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Papillary thyroid carcinoma with desmoid-type fibromatosis: the clinicopathological features with characteristic imaging and molecular correlation requiring comprehensive treatment.
    Huang H; Li L; Liu X; Zhao L; Cui Z; Zhang R; Chen S
    Hum Pathol; 2023 Jun; 136():84-95. PubMed ID: 37019411
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mesonephric-like adenocarcinoma of the ovary with squamoid morular metaplasia, aberrant β-catenin expression, and concurrent FGFR2 and ctnnb1 mutations: a case report.
    Xu J; Park KJ; Rehrauer WM; Weisman PS
    Virchows Arch; 2024 Jan; 484(1):147-150. PubMed ID: 36856760
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma.
    Murai H; Kodama T; Maesaka K; Tange S; Motooka D; Suzuki Y; Shigematsu Y; Inamura K; Mise Y; Saiura A; Ono Y; Takahashi Y; Kawasaki Y; Iino S; Kobayashi S; Idogawa M; Tokino T; Hashidate-Yoshida T; Shindou H; Miyazaki M; Imai Y; Tanaka S; Mita E; Ohkawa K; Hikita H; Sakamori R; Tatsumi T; Eguchi H; Morii E; Takehara T
    Hepatology; 2023 Jan; 77(1):77-91. PubMed ID: 35567547
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast cancer via Sponging miR-149-5p to Up-Regulate CTCF and ctnnb1 to Activate Wnt/β-Catenin Pathway.
    Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S
    Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Objective assessment of adrenocortical carcinoma driver genes and their correlation with tumor pyruvate kinase M2.
    Das R; Ghosh Chowdhury M; Raundal S; Jadhav J; Kumar N; Patel S; Shard A
    Gene; 2022 May; 822():146354. PubMed ID: 35189247
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recognition of the Possible miRNA-mRNA Controlling Network in Stroke by Bioinformatics Examination.
    Li W; Li J; Yang Y
    Comput Math Methods Med; 2021; 2021():6745282. PubMed ID: 34938355
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical and Molecular Characteristics of PRKACA L206R Mutant Cortisol-Producing Adenomas in Korean Patients.
    Jang I; Kim SJ; Song RY; Kim K; Choi S; Lee JS; Gwon MK; Seong MW; Lee KE; Kim JH
    Endocrinol Metab (Seoul); 2021 Dec; 36(6):1287-1297. PubMed ID: 34852451
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the thyroid.
    Bae JS; Jung SH; Hirokawa M; Bychkov A; Miyauchi A; Lee S; Chung YJ; Jung CK
    Endocr Pathol; 2021 Sep; 32(3):336-346. PubMed ID: 34313965
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Higher serum homocysteine and lower thyroid hormone levels in pregnant women are associated with neural tube defects.
    Gu YH; Zhang Q; Guo J; Wang F; Bao Y; Qiu Z; Zheng P; Ushijima M; Matsuura M; Xie X; Zhang T
    J Trace Elem Med Biol; 2021 Dec; 68():126814. PubMed ID: 34243025
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis.
    Zheng L; Li S; Zheng X; Guo R; Qu W
    Int Immunopharmacol; 2021 Jan; 90():107185. PubMed ID: 33218938
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt/β-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma.
    Dai W; Jin X; Han L; Huang H; Ji Z; Xu X; Tang M; Jiang B; Chen W
    Cell Death Dis; 2020 Sep; 11(9):743. PubMed ID: 32917852
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases.
    Suster D; Michal M; Nishino M; Piana S; Bongiovanni M; Blatnik O; Hájková V; Ptáková N; Michal M; Suster S
    Mod Pathol; 2020 Sep; 33(9):1702-1711. PubMed ID: 32291398
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
    Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
    J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior.
    Euscher ED; Bassett R; Duose DY; Lan C; Wistuba I; Ramondetta L; Ramalingam P; Malpica A
    Am J Surg Pathol; 2020 Apr; 44(4):429-443. PubMed ID: 31725471
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature.
    Aydemirli MD; van der Tuin K; Hes FJ; van den Ouweland AMW; van Wezel T; Kapiteijn E; Morreau H
    Fam Cancer; 2020 Jan; 19(1):15-21. PubMed ID: 31598872
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of ctnnb1-mutated medulloblastomas.
    Surun A; Varlet P; Brugières L; Lacour B; Faure-Conter C; Leblond P; Bertozzi-Salomon AI; Berger C; André N; Sariban E; Raimbault S; Prieur F; Desseigne F; Zattara H; Guimbaud R; Polivka M; Delisle MB; Vasiljevic A; Maurage CA; Figarella-Branger D; Coulet F; Guerrini-Rousseau L; Alapetite C; Dufour C; Colas C; Doz F; Bourdeaut F
    Neuro Oncol; 2020 Jan; 22(1):128-138. PubMed ID: 31504825
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.